Department Of Health
Detail of outcome
The results of this call for evidence will inform the development of the next 5-year national action plan (NAP) on antimicrobial resistance (AMR), which will run from 2024 to 2029.
The 2024 to 2029 NAP will continue being developed in consultation with a broad range of stakeholders across different sectors. It will build on the achievements of the 2019 to 2024 NAP, while recognising where there is more for us to do, and it will be aligned with global plans and frameworks for action.
The call for evidence asked questions designed to understand:
- changes in the risk landscape
- progress on tackling AMR to date
- key interventions the government should consider
Thank you to all who responded to the antimicrobial resistance national action plan call for evidence. The findings from the antimicrobial resistance call for evidence will inform further, in-depth engagement with stakeholders. This includes engagement on potential priorities and interventions for consideration.
Detail of feedback received
We received 200 responses to the call for evidence, which ran from 23 November 2022 to 20 January 2023.
Original consultation
Consultation description
The government is developing the next 5-year national action plan on antimicrobial resistance (AMR). The plan will run from 2024 until 2029.
We would like you to tell us your thoughts and evidence for us to consider in making this plan.
We encourage input from technical experts including on human health, animal and plant health, food and AMR in the environment.
In addition to this call for evidence, the government is consulting a wide range of stakeholders across and beyond government.
Antimicrobial resistance is when the organisms that cause infection evolve ways to survive antimicrobial treatment. Once standard treatments are ineffective, it is easier for infections to arise, persist and spread. These resistant organisms can be found in people, animals, food and the environment.
The action plans are part of a programme to tackle AMR and achieve the UKs vision for AMR to be contained and controlled by 2040.